BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6393265)

  • 1. [Detection of circulating immune complexes by immunoenzyme assay with solid phase Clq].
    Mezzano S; López MI
    Rev Med Chil; 1984 Jun; 112(6):547-52. PubMed ID: 6393265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro methods for detection of circulating immune complexes.
    Blackstock R
    Ann Clin Lab Sci; 1981; 11(3):262-8. PubMed ID: 7018370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of circulating immune complexes by enzyme immunoassay. A basic study of C1q enzyme immunoassay and anti-C3 enzyme immunoassay using microplates].
    Yokoyama K
    Arerugi; 1984 Feb; 33(2):117-26. PubMed ID: 6380453
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the composition and elimination of circulating immune complexes in leukaemia.
    Hollán SR; Füst G; Mód A; Puskás E; Nguyen Chi Phi
    Haematologia (Budap); 1980; 13(1-4):263-82. PubMed ID: 7250813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of circulating immune complexes (CIC) in systemic lupus erythematosus (SLE) by 125I-clq binding test (author's transl)].
    Yoshizawa N; Fujita K
    Nihon Jinzo Gakkai Shi; 1979 Oct; 21(10):1157-69. PubMed ID: 529614
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
    Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
    Sølling J; Sølling K; Jacobsen KU
    Acta Derm Venereol; 1979; 59(5):421-6. PubMed ID: 93365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two solid-phase ELISAs for measuring circulating immune complexes in human sera].
    Wahn V; Poleshuck L; Fogel M; Good RA; Day NK
    Med Lab (Stuttg); 1981 Dec; 34(12):331-7. PubMed ID: 7050646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of Fc-rosette. 1. Inhibition of Fc-rosette formation by systemic lupus erythematosus sera. A method for detection of circulating immune complexes].
    Moyito T; Aotsuka S; Yokohari R; Moroi Y; Yokohari R
    Ryumachi; 1976 Mar; 16(1):4-11. PubMed ID: 1085992
    [No Abstract]   [Full Text] [Related]  

  • 11. [C1q solid-phase radioimmunoassay for detection of circulating immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Sato M; Kasukawa R; Suzuki S; Kameda S; Yoshida T
    Ryumachi; 1978 Mar; 18(2):97-103. PubMed ID: 307277
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenetic significance of circulating immune complexes.
    Van Es LA; Daha MR; Valentijn RM; Kauffmann RH
    Neth J Med; 1984; 27(9):350-8. PubMed ID: 6083461
    [No Abstract]   [Full Text] [Related]  

  • 14. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus.
    Frank MM; Hamburger MI; Lawley TJ; Kimberly RP; Plotz PH
    N Engl J Med; 1979 Mar; 300(10):518-23. PubMed ID: 763252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating immune complexes by using human red blood cells.
    Aikawa T; Mitamura T; Tanimoto K; Horiuchi Y
    J Lab Clin Med; 1979 Dec; 94(6):902-16. PubMed ID: 387898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of immune complexes in renal diseases (author's transl)].
    Smolen JS; Wolf A; Scherak O; Syre G; Pinggera W; Stummvoll HK; Leithner C; Menzel EJ
    Acta Med Austriaca; 1981; 8(2):37-41. PubMed ID: 6456639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
    Kasukawa R
    Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M; Todoroki T; Sakai K; Nobunaga M
    J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.